Abstract
AIDS, the fatal disease, caused in human by the fast spreading human immunodeficiency virus (HIV), was detected in 1981. To check its rapid growth, affecting various parts of the world population, there are various FDA approved drugs, released in the market for treating AIDS. These belong to 5 different categories which differ in their mechanism of action. These are i) reverse transcriptase inhibitors, ii) protease inhibitors, iii) fusion inhibitors, iv) entry inhibitors and v) HIV integrase strand transfer inhibitors. These drugs are mostly used in a combination therapy, named as Highly Active Anti Retroviral Therapy (HAART), using 2 to 3 compounds in combination, for a more effective and beneficial treatment. However, none of the drugs can be considered ideal for curing the disease. A study of structural requirement for different types of anti-HIV activities may help in designing a suitable drug for AIDS.
Keywords: Anti HIV, AIDS, protease inhibitor, reverse transcriptase inhibitor, integrase inhibitor, fusion inhibitor
Mini-Reviews in Medicinal Chemistry
Title: Drugs for AIDS
Volume: 10 Issue: 2
Author(s): S. Ray, Z. Fatima and A. Saxena
Affiliation:
Keywords: Anti HIV, AIDS, protease inhibitor, reverse transcriptase inhibitor, integrase inhibitor, fusion inhibitor
Abstract: AIDS, the fatal disease, caused in human by the fast spreading human immunodeficiency virus (HIV), was detected in 1981. To check its rapid growth, affecting various parts of the world population, there are various FDA approved drugs, released in the market for treating AIDS. These belong to 5 different categories which differ in their mechanism of action. These are i) reverse transcriptase inhibitors, ii) protease inhibitors, iii) fusion inhibitors, iv) entry inhibitors and v) HIV integrase strand transfer inhibitors. These drugs are mostly used in a combination therapy, named as Highly Active Anti Retroviral Therapy (HAART), using 2 to 3 compounds in combination, for a more effective and beneficial treatment. However, none of the drugs can be considered ideal for curing the disease. A study of structural requirement for different types of anti-HIV activities may help in designing a suitable drug for AIDS.
Export Options
About this article
Cite this article as:
Ray S., Fatima Z. and Saxena A., Drugs for AIDS, Mini-Reviews in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/138955710791185145
DOI https://dx.doi.org/10.2174/138955710791185145 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
Natural Products in Drug Discovery
Natural products have always been one of the important ways of drug discovery due to their novel skeleton and diverse functional group characteristics. According to statistics, between 1981 and 2019, the FDA approved a total of 1,394 small molecule drugs for marketing, of which 930 marketed drugs originated from the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Treating COPD in Older and Oldest Old Patients
Current Pharmaceutical Design Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies
Current Drug Targets A Critical Review on the Unexplored Therapeutic Treasure of Himalayan Ayurvedic Drug Daruharidra (<i>Berberis Aristata</i>)
Current Traditional Medicine Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design Monobactams: A Unique Natural Scaffold of Four-Membered Ring Skeleton, Recent Development to Clinically Overcome Infections by Multidrug- Resistant Microbes
Letters in Drug Design & Discovery Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Current Pharmaceutical Design The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands
Current Neuropharmacology Emerging Therapy for Diabetic Neuropathy: Cell Therapy Targeting Vessels and Nerves
Endocrine, Metabolic & Immune Disorders - Drug Targets Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design Agonists and Antagonists of Protease Activated Receptors (PARs)
Current Medicinal Chemistry Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery
Current Pharmaceutical Design Diagnosis and Treatment of Paraneoplastic Neurological Syndromes
Current Clinical Pharmacology Prospects for Discovering the Secondary Metabolites of <i>Cordyceps</i> Sensu Lato by the Integrated Strategy
Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry A Possible Placental Factor for Preeclampsia: sFlt-1
Current Medicinal Chemistry Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry What have Genetically Engineered Mice Taught Us About Ischemic Injury?
Current Molecular Medicine Natural Products Based Ayurvedic Formulations: Chemical Cons tituents and Treatment in Neurodegenerative Disordersǂ
Mini-Reviews in Organic Chemistry Chilling-Like Attacks Terminated by Slow Pathway Ablation
Current Cardiology Reviews